Skip to main content

MapLight Therapeutics, Inc.

MPLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001770069

In the last 90 days, MapLight Therapeutics, Inc. insiders filed 3 open-market purchases and 8 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $941.0M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by MapLight Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
3 filings
2 insiders, $65.5M in total
Open-market sells
8 filings
6 insiders, $11.6M in total
Insiders trading
8
Net value
+$53.9M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for MapLight Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for MapLight Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hanson KristopherGeneral Counsel137,044Sep 18, 20269
Kreitzer AnatolChief Discovery Officer180,926Aug 19, 20267
Gillis JonathanCAO and Interim CFO152,482Aug 19, 20267
Lillie James WoodruffChief Scientific Officer210,110Aug 19, 20269
Foff Erin PennockChief Medical Officer312,261Aug 19, 20268
Kroeger Christopher A.Chief Executive Officer1,269,600Aug 19, 20269
Catalyst4, Inc.10% Owner25,306,689IndirectAug 18, 20263
Cox TroyDirector15,620IndirectJul 28, 20262
Babler MartinDirector7,864Jun 25, 20261
Pavlov GeorgeDirector28,932Jun 25, 20262
Walker Maria CDirector62,703Jun 25, 20262
Garnett Timothy JohnDirector53,457Jun 25, 20263
Luneborg Nanna LiebachDirector3,932Jun 25, 20261
Setia VishwasChief Financial Officer356,256May 6, 20265
Malenka Robert C.Director316,466Apr 17, 20267
Novo Holdings A/S10% Owner3,686,622Oct 30, 20251

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2026 (view filing)4:15 PM ETSep 162 daysHanson KristopherGeneral CounselSSaleVoting Common Stock−16.5K$11.67−$192.7K−10.8%137.0K after10b5-1
Aug 18, 2026 (view filing)6:55 PM ETAug 144 daysCatalyst4, Inc.10% OwnerPPurchaseVoting Common Stock+4.40M$11.38+$50.1M+21.0%25.3M after
Aug 18, 2026 (view filing)6:55 PM ETAug 144 daysCatalyst4, Inc.10% OwnerPPurchaseVoting Common Stock+2.93M$11.38+$33.3M–2.93M afterDerivative
Aug 4, 2026 (view filing)8:39 PM ETAug 31 dayLillie James WoodruffChief Scientific OfficerSSaleVoting Common Stock−22.1K$12.54−$276.9K−9.8%202.4K after10b5-1
Jul 30, 2026 (view filing)6:39 PM ETJul 28-302 daysCatalyst4, Inc.10% OwnerPPurchaseVoting Common Stock+1.21M$12.66+$15.3M+6.1%20.9M after4 lots
Jul 28, 2026 (view filing)9:14 PM ETJul 28Same dayCox TroyDirectorPPurchaseVoting Common Stock+15.6K$9.52+$148.7KNew position15.6K after
Jul 20, 2026 (view filing)6:00 AM ETJul 15-175 daysLateGillis JonathanCAO and Interim CFOSSaleVoting Common Stock−37.0K$37.12−$1.37M−20.4%144.2K after7 lots10b5-1
Jul 20, 2026 (view filing)6:00 AM ETJul 15-175 daysLateKreitzer AnatolChief Discovery OfficerSSaleVoting Common Stock−36.3K$37.09−$1.35M−17.2%174.9K after7 lots10b5-1
Jul 17, 2026 (view filing)9:46 PM ETJul 15-172 daysKroeger Christopher A.Chief Executive OfficerSSaleVoting Common Stock−147.6K$36.87−$5.44M−10.6%1.25M after7 lots
Jul 17, 2026 (view filing)9:45 PM ETJul 15-172 daysLillie James WoodruffChief Scientific OfficerSSaleVoting Common Stock−18.3K$36.88−$673.6K−7.5%224.5K after7 lots
Jul 17, 2026 (view filing)9:44 PM ETJul 15-172 daysHanson KristopherGeneral CounselSSaleVoting Common Stock−16.5K$36.82−$607.9K−10.2%145.8K after7 lots
Jul 17, 2026 (view filing)9:43 PM ETJul 15-172 daysFoff Erin PennockChief Medical OfficerSSaleVoting Common Stock−47.2K$36.78−$1.73M−13.6%298.9K after9 lots10b5-1
May 18, 2026 (view filing)May 18Same dayKroeger Christopher A.Chief Executive OfficerSSaleVoting Common Stock−118.2K$27.19−$3.21M−7.8%1.39M after2 lots10b5-1
May 11, 2026 (view filing)May 74 daysFoff Erin PennockChief Medical OfficerSSaleVoting Common Stock−4.44K$28.54−$126.6K−1.3%346.1K after2 lots10b5-1
May 11, 2026 (view filing)May 11Same dayHanson KristopherGeneral CounselSSaleVoting Common Stock−13.9K$30.13−$419.3K−7.9%162.3K after4 lots10b5-1
May 11, 2026 (view filing)May 74 daysLillie James WoodruffChief Scientific OfficerSSaleVoting Common Stock−721$28.28−$20.4K−0.3%242.7K after10b5-1
May 11, 2026 (view filing)May 7-114 daysKroeger Christopher A.Chief Executive OfficerSSaleVoting Common Stock−68.5K$28.47−$1.95M−4.3%1.51M after9 lots10b5-1
May 6, 2026 (view filing)May 4-62 daysSetia VishwasChief Financial OfficerSSaleVoting Common Stock−36.4K$28.17−$1.02M−9.3%356.3K after8 lots10b5-1
May 6, 2026 (view filing)May 4-62 daysFoff Erin PennockChief Medical OfficerSSaleVoting Common Stock−50.3K$28.39−$1.43M−12.5%350.5K after8 lots10b5-1
May 6, 2026 (view filing)May 42 daysHanson KristopherGeneral CounselSSaleVoting Common Stock−13.9K$27.89−$388.2K−7.3%176.2K after4 lots10b5-1
May 6, 2026 (view filing)May 4-62 daysLillie James WoodruffChief Scientific OfficerSSaleVoting Common Stock−51.7K$28.40−$1.47M−17.5%243.4K after8 lots10b5-1
May 6, 2026 (view filing)May 4-62 daysKroeger Christopher A.Chief Executive OfficerSSaleVoting Common Stock−49.7K$28.39−$1.41M−3.1%1.58M after8 lots10b5-1
Apr 29, 2026 (view filing)Apr 272 daysKreitzer AnatolChief Discovery OfficerSSaleVoting Common Stock−45.4K$29.66−$1.35M−17.7%211.2K after3 lots10b5-1
Apr 29, 2026 (view filing)Apr 27-282 daysGillis JonathanCAAO and PAOSSaleVoting Common Stock−69.8K$29.89−$2.09M−27.8%181.2K after5 lots10b5-1
Apr 17, 2026 (view filing)Apr 15-162 daysSetia VishwasChief Financial OfficerSSaleVoting Common Stock−2.92K$26.89−$78.6K−0.7%392.6K after3 lots
Apr 17, 2026 (view filing)Apr 152 daysKreitzer AnatolChief Discovery OfficerSSaleVoting Common Stock−3.32K$26.61−$88.2K−1.3%256.6K after
Apr 17, 2026 (view filing)Apr 15-162 daysFoff Erin PennockChief Medical OfficerSSaleVoting Common Stock−3.21K$27.03−$86.9K−0.8%400.8K after3 lots
Apr 17, 2026 (view filing)Apr 152 daysMalenka Robert C.DirectorSSaleVoting Common Stock−8.59K$26.90−$231.2K−2.6%316.5K after10b5-1
Apr 17, 2026 (view filing)Apr 15-162 daysHanson KristopherGeneral CounselSSaleVoting Common Stock−1.83K$26.89−$49.1K−1.0%190.2K after3 lots
Apr 17, 2026 (view filing)Apr 15-162 daysLillie James WoodruffChief Scientific OfficerSSaleVoting Common Stock−4.51K$27.16−$122.6K−1.5%295.2K after3 lots
Apr 17, 2026 (view filing)Apr 152 daysGillis JonathanCAAO and PAOSSaleVoting Common Stock−3.59K$26.61−$95.5K−1.4%251.1K after
Apr 17, 2026 (view filing)Apr 15-162 daysKroeger Christopher A.Chief Executive OfficerSSaleVoting Common Stock−19.2K$27.16−$521.1K−1.2%1.63M after3 lots
Feb 24, 2026 (view filing)Feb 20-244 daysMalenka Robert C.DirectorSSaleVoting Common Stock−14.2K$18.34−$260.4K−4.2%325.1K after4 lots
Feb 20, 2026 (view filing)Feb 18-202 daysPavlov GeorgeDirectorPPurchaseVoting Common Stock+25.0K$17.65+$441.2KNew position25.0K after3 lots
Feb 18, 2026 (view filing)Feb 135 daysMalenka Robert C.DirectorSSaleVoting Common Stock−12.1K$18.21−$220.6K−3.4%339.3K after
Feb 12, 2026 (view filing)Feb 10-112 daysMalenka Robert C.DirectorSSaleVoting Common Stock−6.86K$18.12−$124.3K−1.9%351.4K after2 lots
Feb 12, 2026 (view filing)Feb 102 daysGarnett Timothy JohnDirectorPPurchaseVoting Common Stock+14.1K$17.89+$252.7KNew position14.1K after
Feb 4, 2026 (view filing)Feb 2-32 daysMalenka Robert C.DirectorSSaleVoting Common Stock−7.04K$18.02−$126.9K−1.9%358.2K after2 lots
Jan 30, 2026 (view filing)Jan 28-302 daysMalenka Robert C.DirectorSSaleVoting Common Stock−34.4K$18.49−$635.9K−8.6%365.3K after4 lots
Oct 30, 2025 (view filing)Oct 282 daysNovo Holdings A/S10% OwnerPPurchaseVoting Common Stock+952.9K$17.00+$16.2M+34.9%3.69M after
Oct 29, 2025 (view filing)Oct 281 dayCatalyst4, Inc.10% OwnerPPurchaseVoting Common Stock+5.44M$17.00+$92.5M+38.2%19.7M after